Seeing Is Believing
with an average price target of $31.6. This is a potential upside of $31.6 (0%) from yesterday's end of day stock price of $0.
Turning Point Therapeutics's activity chart (see below) currently has 78 price targets and 50 ratings on display.
Analysts average stock forecasts to be materialized ratio is 58.57% with an average time for these price targets to be met of 76.08 days.
Most recent stock forecast was given by ANDREW BERENS from LEERINK on 13-Jun-2022.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$76
$-0.01 (-0.01%)
$101
2 years 5 months 8 days ago
(13-Jun-2022)
3/4 (75%)
$1.72 (2.32%)
29
Hold
$76
$-0.01 (-0.01%)
2 years 5 months 15 days ago
(06-Jun-2022)
4/6 (66.67%)
$1.25 (1.67%)
64
Hold
$76
$-0.01 (-0.01%)
$61
2 years 5 months 18 days ago
(03-Jun-2022)
4/5 (80%)
$1.41 (1.89%)
73
Hold
$45
$-31.01 (-40.80%)
$75
2 years 8 months 20 days ago
(01-Mar-2022)
2/2 (100%)
$14.21 (46.15%)
179
Buy
$85
$8.99 (11.83%)
$120
2 years 9 months 11 days ago
(10-Feb-2022)
4/6 (66.67%)
$49.25 (137.76%)
99
What is TPTX (Turning Point Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on TPTX (Turning Point Therapeutics) with a proven track record?
Which analyst has the most public recommendations on TPTX (Turning Point Therapeutics)?
Which analyst is the currently most bullish on TPTX (Turning Point Therapeutics)?
Which analyst is the currently most reserved on TPTX (Turning Point Therapeutics)?